Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Docetaxel plus oxaliplatin (DOCOX) as a second-line treat... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer
0
Authors
Haijun Zhong
10 more
Haijun Zhong
•
Yiping Zhang
8 more
•
Daoyuan Wang
Published
November 1, 2008
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Anti-Cancer Drugs
Topics
Medicine
Cancer Oncology
Internal Medicine
Surgery
Gastroenterology
Show all topics
DOI
10.1097/cad.0b013e328314b5ab
